Renaissance Capital counted 30 US IPOs in the third quarter of 2026 raising $32.8 billion, but $26.5 billion of that came from a single offering by SK hynix. Strip that deal out and proceeds were $6.2 billion, and several well-known issuers have since pulled their plans. For owners and investors who see a public listing as a possible exit, the window is open but narrower than the headline total suggests.
Renaissance Capital titled its quarterly review "Fall IPO Pickup Stumbles on AI Concerns and Rising Rates," and the numbers explain why. Of the 30 listings, 18 raised $100 million or more, which is a healthier spread of company types than earlier quarters. Biotech and AI infrastructure remained the dominant themes. But the aggregate figure was carried by one very large foreign issuer, and more offerings were postponed as the quarter closed.
The pattern matters more than any single deal. A market with one oversized transaction and a thin middle can look strong in a summary table while offering little to a typical issuer. Owners reading the headline total should ask what the median offering looked like, and how many companies were willing to launch at all.
An IPO prices off what public investors will pay today for earnings that arrive in the future. When the yield on a safe asset rises, that future stream is worth less in present terms. Analysts call this the discount rate, and it is the reason higher yields hit growth companies hardest: more of their value sits in earnings that are further away.
The 10-year Treasury yield recently rose to nearly 5.3%, its highest level since 2007, and the Federal Reserve raised rates in September for the first time since 2023. Investors can now earn a meaningful return without taking equity risk, so they ask more of a new listing. Concerns about AI spending have added a second source of caution for companies tied to that theme.
Oura, the smart ring maker, postponed a Nasdaq offering that would have valued it near $15 billion. Its revenue was $1.2 billion over the nine months to June 30, up from $697 million a year earlier, and press reports said the book was roughly four times oversubscribed. The company cited market uncertainty. Holtec International and Bamboo Insurance also delayed their offerings.
The Oura case shows how an issuer can have strong demand and still wait. Demand at one price is not the same as demand at the price the company and its existing shareholders want. Academic observers have pointed out that valuations of this kind assume high growth continues, and when growth slows, public markets reprice quickly. A delay lets management preserve the valuation it believes the business has earned, and it keeps the company's options open.
Contrast that with Jersey Mike's, the Blackstone-backed sandwich chain, which priced its IPO this summer at $23, the midpoint of its range, raised more than $1 billion, and traded about 6% lower on its first day. The company completed the listing, but a midpoint price and a weak debut show how little cushion public investors are leaving for issuers.

Most owner-operated companies are far smaller than the issuers named here, and a public listing is not a realistic path for them. The same market forces still reach them in two ways. First, public company valuations act as a reference point for buyers: when listed multiples fall, private buyers use that to argue for lower prices. Second, private equity firms that planned to exit portfolio companies through an IPO are now more likely to sell those companies to other buyers, which adds supply to the private market and competes with owners for strategic attention.
For the smaller group of owners and investors who do have a listing in view, the practical response is a dual-track process. That means preparing the company for an IPO (audited financials, public company reporting controls, a credible equity story) while also running a confidential sale process with selected buyers. The IPO preparation work, such as clean audited numbers and a clear quality of earnings analysis (an independent review of how much reported profit is repeatable), also raises the price a private buyer will pay.
Three signals will tell owners whether the window widens or narrows. The first is the path of Treasury yields and the Fed's next decision, since further increases would extend the pressure on growth valuations. The second is how recent IPOs trade after pricing; weak aftermarket performance makes the next issuer more cautious about price. The third is whether postponed companies return quickly or wait until the new year, which would show how much of the pause is about rates and how much is about valuation expectations.
None of these signals requires an owner to act today. They do argue for keeping financial reporting current and options documented, so that whichever path opens first can be used without a long preparation period.
Public markets are open but selective, and rising yields are asking more of every new listing. Owners and investors comparing an IPO with a private sale should plan for both paths, keep audited numbers ready, and avoid anchoring on a quarterly total that one large offering drove. The companies best placed to choose their timing are the ones that prepared early.